Quote:
Originally Posted by UGAalum94
That was really interesting. It's a little disappointing that the treatment, when given for leukemia, kills 30% of its patients, but it is a new avenue of hope.
I also wonder why there's no widespread promotion of testing to see if people have the mutation that prevents infection. And it's interesting to wonder why, as uncommon as it is, why it's more common in Northern Europeans. What was the evolutionary issue?
|
From what I read a while ago, and unable to find anything good on it at this time, it has to do with the manner the black death or one of the plagues that afflicted Europe. Something to do with the manner in which the plagues attacked the human body and that CCR5 molecule is what it attached to [similar to HIV] to attack the cells.
This isn't real clear, sorry, started drinking early today.
Hybrid Mode
